This website is intended for journalists outside the US/UK, who are interested in media information from Boehringer Ingelheim.

Education Hub

 

Acute Myeloid Leukaemia Awareness Survey

Acute myeloid leukaemia (AML) is a devastating form of blood cancer that mainly affects people over 60 years old. For older patients who receive chemotherapy, the median survival is less than a year.

A perception and awareness survey of 2,520 people from France, Germany, Italy, Spain and UK. conducted in 2014 revealed urgent need to improve education about AML.

Therapy Area

Filter by therapy area :

Infographics

 

  •   

    GIOTRIF® (AFATINIB*) NOW APPROVED IN OVER 40 COUNTRIES WORLDWIDE

  •  

    VOLASERTIB* AND POLO-LIKE KINASE INHIBITION

  •  

    LUME-LUNG 1 INFOGRAPHIC

  •  

    LUX-LUNG 3 & 6 CLINICAL TRIAL RESULTS LAYERED INFOGRAPHIC

  •  

    AFATINIB* - IRREVERSIBLE ERBB FAMILY BLOCKER

  •  

    LUNG CANCER STATISTICS

  •  

    LUX-LUNG 5 INFOGRAPHIC

  •    

    LUX-LUNG 7 CLINICAL TRIAL INFOGRAPHIC

  •  

    LUX-Lung 8 Clinical Trial Infographic

  •  

    LUX-Lung Clinical Trial Programme Infographic


  •  

    ANGIOKINASE INHIBITION AND NINTEDANIB*

  •  

    LUNG CANCER ANIMATED INFOGRAPHIC

  •  

    AGO-OVAR, LUME-OVAR OVARIAN CANCER CLINICAL TRIALS

  •  

    LUX-HEAD & NECK 1 TRIAL INFOGRAPHIC

  •  

    LUX-HEAD & NECK 2 TRIAL INFOGRAPHIC

  •  

    BREAST CANCER SYMPTOMS ANIMATED INFOGRAPHIC

  •  

    OVARIAN CANCER ANIMATED INFOGRAPHIC

  •  

    BREAST CANCER SYMPTOMS ANIMATED INFOGRAPHIC

  •  

    LUME LUNG 2 CLINICAL TRIAL INFOGRAPHIC

  •  

    LUME LUNG 1 CLINICAL TRIAL INFOGRAPHIC

  •    

    LUX LUNG 1 CLINICAL TRIAL INFOGRAPHIC

  •  

    LUX LUNG 2 CLINICAL TRIAL INFOGRAPHIC

  •  

    THE CHANGING FACE OF CANCER INFOGRAPHIC

  •  

    OVARIAN CANCER STATISTICS INFOGRAPHIC

  •  

    BREAST CANCER STATISTICS INFOGRAPHIC

  •  

    Volasertib* And Polo-Like Kinase Inhibition

  •   

    HEAD AND NECK CANCER INCIDENCE &STATISTICS INFOGRAPHIC

  •  

    POLO-AML-2

  •   

    Acute Myeloid Leukaemia

    Videos

     

    •     

      LUX-LUNG 3 & 6: overall survival analysis

    •  

      ACUTE MYELOID LEUKAEMIA: A RARE DISEASE

    •  

      LUNG CANCER - HEAR FROM A PATIENT & AND LUNG CANCER: WE'RE LISTENING - DR. MATTHEW PETERS 

    •   

      BI ONCOLOGY NEWS: THE ASIAN PATIENT PERSPECTIVE

    •    

      NINTEDANIB* MODE OF ACTION

    •    

      EGFR MUTATIONS IN LUNG CANCER VIDEO

    •    

      LUNG CANCER, NOT JUST ONE DISEASE

    •   

      LUX-Lung 3 & 6 trials video

    •   

      Lung cancer, not just one disease - Dr. Sanjay Popat

    •  

      Lung cancer, not just one disease

    •  

      Importance of EGFR Mutation Testing

    •  

      ASCO 2013 afatinib* and nintedanib* data story

    •  

      LUX-Lung 3 Trial Design

    •  

      LUX-Lung 3 Results - Prof Thomas Lynch

    •   

      lux lung 6 and other afatinib trials

    •  

      LUX-Lung 7 & 8 Trials

    •  

      Lung cancer biomarkers

    •  

      AFATINIB LUNG CANCER TREATMENT - NSCLC WITH EGFR MUTATION

    •   

      OVARIAN CANCER RESEARCH AND NEW TREATMENT OPTIONS

    •   

      OVARIAN CANCER SYMPTOMS AND CHARACTERISTICS

    •   

      OVARIAN CANCER TREATMENT - TARGETED THERAPIES

    •   

      OVARIAN CANCER PROGNOSIS & LATE DIAGNOSIS

    •   

      HEAD AND NECK CANCER INCIDENCE AND PROGNOSIS

    •    

      HEAD AND NECK CANCER TREATMENTS & TARGETED THERAPIES

    •   

      AFATINIB HEAD AND NECK CANCER TRIALS

    •  

      TARGETED LUNG CANCER TREATMENT

    •   

      IMPROVING OUTCOMES IN LUNG CANCER

    •   

      PERSONALISING CANCER CARE AND THE FUTURE OF CANCER TREATMENTS

    •  

      PERSONALISED CANCER TREATMENT - CANCER AS CHRONIC DISEASE

    •   

      NON SMALL CELL LUNG CANCER OVERVIEW

    •   

      EGFR MODE OF ACTION

    •   

      VOLASERTIB* PLK 1 INHIBITOR - ONCOLOGY COMPOUND

    •     

      LUME-Lung 1 trial - Dr. Martin Reck

    •     

      Lung Cancer - hear from a patient & an oncology nurse

      Backgrounder

       

      •  

        GIOTRIF® (AFATINIB®)  Backgrounder

      •  

        Lung Cancer Backgrounder

      •   

        Boehringer Ingelheim Oncology Research and Development

      •  

        Volasertib* Backgrounder

      •  

        NINTEDANIB* BACKGROUNDER

      •  

        ERBB FAMILY BACKGROUNDER

      •  

        Acute Myeloid Leukaemia (AML) Backgrounder

      •      

        TARGETED CANCER THERAPIES BACKGROUNDER

      •    

        CANCER STATISTICS AND INCIDENCE RATES

      •      

        BREAST CANCER OVERVIEW - WHAT IS BREAST CANCER?

      •     

        WHAT IS OVARIAN CANCER? BACKGROUNDER

      •      

        HEAD AND NECK CANCER OVERVIEW AND BACKGROUNDER

        Fact sheet

         

        •  

          GLOSSARY OF TERMS

        •  

          LUX-LUNG 3 CLINICAL TRIAL FACT SHEET

        •  

          LUX LUNG 2 CLINICAL TRIAL FACT SHEET

        •  

          A-Z CANCER GLOSSARY

        •  

          LUX LUNG 1 CLINICAL TRIAL FACT SHEET